Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Pembrolizumab (Primary) ; Docetaxel; Doxorubicin
- Indications Carcinoma; Thyroid cancer
- Focus Therapeutic Use
- 14 Feb 2018 Status changed from recruiting to suspended.
- 16 Aug 2017 Status changed from not yet recruiting to recruiting.
- 10 Jul 2017 New trial record